Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation
Joy M. Schmitz, Nuvan Rathnayaka, Charles E. Green, et al.
Frontiers in Psychiatry (2012) Vol. 3
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research
Paul W. Czoty, William W. Stoops, Craig R. Rush
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 533-562
Open Access | Times Cited: 125
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
Psychostimulant drugs for cocaine dependence
Xavier Castells, Ruth Cunill, Clara Pérez‐Mañá, et al.
Cochrane library (2016) Vol. 2016, Iss. 9
Open Access | Times Cited: 96
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

Journal of Addiction Medicine (2024) Vol. 18, Iss. 1S, pp. 1-56
Closed Access | Times Cited: 13
Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial
Mascha Nuijten, Peter Blanken, Ben van de Wetering, et al.
The Lancet (2016) Vol. 387, Iss. 10034, pp. 2226-2234
Closed Access | Times Cited: 79
A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence
Kyle M. Kampman, Kevin G. Lynch, Helen M. Pettinati, et al.
Drug and Alcohol Dependence (2015) Vol. 155, pp. 105-110
Open Access | Times Cited: 78
Psychostimulant addiction treatment
Karran A. Phillips, David H. Epstein, Kenzie L. Preston
Neuropharmacology (2014) Vol. 87, pp. 150-160
Open Access | Times Cited: 73
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?
Laura Brandt, Thomas Chao, Sandra D. Comer, et al.
Addiction (2020) Vol. 116, Iss. 4, pp. 694-710
Open Access | Times Cited: 64
Understanding Stimulant Use and Use Disorders in a New Era
Daniel Ciccarone, Steven Shoptaw
Medical Clinics of North America (2021) Vol. 106, Iss. 1, pp. 81-97
Open Access | Times Cited: 46
The self‐medication hypothesis and psychostimulant treatment of cocaine dependence: An update
John J. Mariani, Edward J. Khantzian, Frances R. Levin
American Journal on Addictions (2013) Vol. 23, Iss. 2, pp. 189-193
Open Access | Times Cited: 67
Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy
Daryl Shorter, Coreen Domingo, Thomas R. Kosten
Expert Opinion on Emerging Drugs (2014) Vol. 20, Iss. 1, pp. 15-29
Closed Access | Times Cited: 57
A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa–carbidopa, naltrexone
Joy M. Schmitz, Charles E. Green, Angela L. Stotts, et al.
Drug and Alcohol Dependence (2014) Vol. 136, pp. 100-107
Open Access | Times Cited: 54
Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users
Frances R. Levin, John J. Mariani, Martina Pavlicová, et al.
Drug and Alcohol Dependence (2019) Vol. 206, pp. 107700-107700
Open Access | Times Cited: 44
Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction
Matthew L. Banks, Blake A. Hutsell, Kathryn L. Schwienteck, et al.
Current Treatment Options in Psychiatry (2015) Vol. 2, Iss. 2, pp. 136-150
Open Access | Times Cited: 46
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study
Christopher D. Verrico, Colin N. Haile, James J. Mahoney, et al.
Drug and Alcohol Dependence (2014) Vol. 141, pp. 72-78
Open Access | Times Cited: 42
Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys.
Joshua A. Lile, Amy R. Johnson, Matthew L. Banks, et al.
Experimental and Clinical Psychopharmacology (2019) Vol. 28, Iss. 2, pp. 169-180
Open Access | Times Cited: 35
Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys
Matthew L. Banks, Bruce E. Blough, S. Stevens Negus
Drug and Alcohol Dependence (2013) Vol. 131, Iss. 3, pp. 204-213
Open Access | Times Cited: 40
Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial
Marc Mooney, David V. Herin, Sheila Specker, et al.
Drug and Alcohol Dependence (2015) Vol. 153, pp. 94-103
Open Access | Times Cited: 39
Modafinil and sleep architecture in an inpatient–outpatient treatment study of cocaine dependence
Peter Morgan, Gustavo A. Angarita, Sofija V. Canavan, et al.
Drug and Alcohol Dependence (2016) Vol. 160, pp. 49-56
Open Access | Times Cited: 38
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research
William W. Stoops, Craig R. Rush
Expert Review of Clinical Pharmacology (2014) Vol. 7, Iss. 3, pp. 363-374
Open Access | Times Cited: 34
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications
Christopher D. Verrico, Colin N. Haile, Thomas F. Newton, et al.
Expert Opinion on Investigational Drugs (2013) Vol. 22, Iss. 12, pp. 1549-1568
Open Access | Times Cited: 32
Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis
Dinesh Sangroula, Fatima Motiwala, Bivek Wagle, et al.
Substance Use & Misuse (2017) Vol. 52, Iss. 10, pp. 1292-1306
Closed Access | Times Cited: 32
Medications to treat cocaine use disorders
Jonathan Buchholz, Andrew J. Saxon
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 4, pp. 275-281
Closed Access | Times Cited: 28
Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience
Justin C. Strickland, William W. Stoops, Matthew L. Banks, et al.
Journal of the Experimental Analysis of Behavior (2022) Vol. 117, Iss. 3, pp. 384-403
Open Access | Times Cited: 15
The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats
Clayton T. Bauer, Matthew L. Banks, S. Stevens Negus
Psychopharmacology (2014) Vol. 231, Iss. 12, pp. 2461-2470
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top